
Related
Related Companies
NSE
BSE
Motilal Oswal has given a buy rating to Lupin with a target price of Rs 1130. The share price moved down by 0.44 per cent from its previous close of Rs 935.95. The stock’s last traded price is Rs 930.40.
Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 42332.65 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 3781.79 Crore, up 7.20 % from last quarter Sales of Rs 3527.86 Crore and down -11.99 % from last year same quarter Sales of Rs 4296.90 Crore Company reported net profit after tax of Rs 213.08 Crore in latest quarter.
Investment Rationale
The brokerage values LPC at 25x 12M forward earnings to arrive at Target Price of INR1,130.
Promoter/FII Holdings
Promoters held 46.9 per cent stake in the company as of Sept 30, 2020, while FIIs held 20.4 per cent, DIIs 20.1 per cent and public and others 12.6 per cent.
Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 42332.65 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 3781.79 Crore, up 7.20 % from last quarter Sales of Rs 3527.86 Crore and down -11.99 % from last year same quarter Sales of Rs 4296.90 Crore Company reported net profit after tax of Rs 213.08 Crore in latest quarter.
Investment Rationale
The brokerage values LPC at 25x 12M forward earnings to arrive at Target Price of INR1,130.
Promoter/FII Holdings
Promoters held 46.9 per cent stake in the company as of Sept 30, 2020, while FIIs held 20.4 per cent, DIIs 20.1 per cent and public and others 12.6 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.